The Performance of Gene Expression Signature-Guided Drug–Disease Association in Different Categories of Drugs and Diseases
A gene expression signature (GES) is a group of genes that shows a unique expression profile as a result of perturbations by drugs, genetic modification or diseases on the transcriptional machinery. The comparisons between GES profiles have been used to investigate the relationships between drugs, t...
Main Authors: | Xiguang Qi, Mingzhe Shen, Peihao Fan, Xiaojiang Guo, Tianqi Wang, Ning Feng, Manling Zhang, Robert A. Sweet, Levent Kirisci, Lirong Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-06-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/25/12/2776 |
Similar Items
-
Identification of Prognostic Signature and Gliclazide as Candidate Drugs in Lung Adenocarcinoma
by: Yang Cheng, et al.
Published: (2021-06-01) -
An Integrated In Silico and In Vivo Approach to Identify Protective Effects of Palonosetron in Cisplatin-Induced Nephrotoxicity
by: Eri Wakai, et al.
Published: (2020-12-01) -
Statistically controlled identification of differentially expressed genes in one-to-one cell line comparisons of the CMAP database for drug repositioning
by: Jun He, et al.
Published: (2017-09-01) -
Identification of Reduced Host Transcriptomic Signatures for Tuberculosis Disease and Digital PCR-Based Validation and Quantification
by: Harriet D. Gliddon, et al.
Published: (2021-03-01) -
Predict New Therapeutic Drugs for Hepatocellular Carcinoma Based on Gene Mutation and Expression
by: Liang Yu, et al.
Published: (2020-01-01)